title: Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency.
authors.affiliation: Department of Internal Medicine, Service d'Asthmologie-Allergologie-Médecine Interne, CHU de Nîmes, Nîmes, France. Electronic address: denis.vincent@chu-nimes.fr.
authors.forename: Denis
authors.initials: D
authors.lastname: Vincent
authors.affiliation: Service de Biochimie, CHU de Grenoble, Grenoble, France.
authors.forename: Denise
authors.initials: D
authors.lastname: Ponard
authors.affiliation: Service d'Asthmologie-Allergologie-Médecine Interne, CHU de Nîmes, Nîmes, France.
authors.forename: Sandrine
authors.initials: S
authors.lastname: Fiorella
authors.affiliation: Department of Biochemistry, Université Joseph Fourier, Centre de Référence des Angioedèmes & Immunogénétique HLA, CHU Grenoble, Grenoble, France.
authors.forename: Christian
authors.initials: C
authors.lastname: Drouet
mesh_terms: D000368:Aged; D000799:Angioedema / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D054179:Angioedemas, Hereditary / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D019138:Antibodies, Blocking / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D015551:Autoimmunity; D003174:Complement C1 Inactivator Proteins / Q000276:immunology* / Q000378:metabolism; D050718:Complement C1 Inhibitor Protein; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage*; D007166:Immunosuppressive Agents; D010949:Plasma / Q000378:metabolism; D012008:Recurrence; D014148:Tranexamic Acid / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D019138:Antibodies, Blocking; D001323:Autoantibodies; D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; D007166:Immunosuppressive Agents; C469952:SERPING1 protein, human; D006886:Hydroxychloroquine; D014148:Tranexamic Acid